Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status and Forecast (2016-2027)
      • 1.3.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Supply by Company

    • 2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value by Company
    • 2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status by Category

    • 3.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Category Introduction
      • 3.1.1 Delafloxacin
      • 3.1.2 Vancomycin
      • 3.1.3 Ceftaroline Fosamil
      • 3.1.4 Others
    • 3.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status by End User/Segment

    • 4.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Segment by End User/Segment
      • 4.1.1 Cellulitis
      • 4.1.2 Abscess
      • 4.1.3 Surgical Wounds
      • 4.1.4 Traumatic Wound
    • 4.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status by Region

    • 5.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Region
    • 5.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status
    • 5.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status
    • 5.4 Asia Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status
    • 5.5 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status
    • 5.6 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status

    6 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status

    • 6.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status

    • 7.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status

    • 8.1 Asia Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status

    • 9.1 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Status

    • 10.1 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Forecast by Category and by End User/Segment

    • 12.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value Forecast (2022-2027)
    • 12.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecast by Category
    • 12.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecast by End User/Segment

    13 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Forecast by Region/Country

    • 13.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Zavante Therapeutics, Inc.
      • 14.1.1 Company Information
      • 14.1.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Introduction
      • 14.1.3 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Teva Pharmaceuticals Industries Ltd.
      • 14.2.1 Company Information
      • 14.2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Introduction
      • 14.2.3 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Sanofi
      • 14.3.1 Company Information
      • 14.3.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Introduction
      • 14.3.3 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Pfizer, Inc.
      • 14.4.1 Company Information
      • 14.4.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Introduction
      • 14.4.3 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Paratek Pharmaceuticals, Inc.
      • 14.5.1 Company Information
      • 14.5.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Introduction
      • 14.5.3 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 MerLion Pharmaceuticals Pte Ltd.
      • 14.6.1 Company Information
      • 14.6.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Introduction
      • 14.6.3 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Merck & Co, Inc.
      • 14.7.1 Company Information
      • 14.7.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Introduction
      • 14.7.3 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Melinta Therapeutics, Inc.
      • 14.8.1 Company Information
      • 14.8.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Introduction
      • 14.8.3 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Macrolide Pharmaceuticals, Inc.
      • 14.9.1 Company Information
      • 14.9.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Introduction
      • 14.9.3 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 GlaxoSmithKline plc
      • 14.10.1 Company Information
      • 14.10.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Introduction
      • 14.10.3 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Furiex Pharmaceuticals, Inc.
    • 14.12 Durata Therapeutics, Inc.
    • 14.13 Debiopharm International S.A.
    • 14.14 Cempra, Inc.
    • 14.15 Bayer AG
    • 14.16 AstraZeneca
    • 14.17 Allergan plc.
    • 14.18 Albany Molecular Research, Inc.
    • 14.19 Actelion Pharmaceuticals Ltd.
    • 14.20 Abbott Laboratories, Inc.

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Delafloxacin
      Vancomycin
      Ceftaroline Fosamil
      Others

      Segmented by End User/Segment
      Cellulitis
      Abscess
      Surgical Wounds
      Traumatic Wound

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Zavante Therapeutics, Inc.
      Teva Pharmaceuticals Industries Ltd.
      Sanofi
      Pfizer, Inc.
      Paratek Pharmaceuticals, Inc.
      MerLion Pharmaceuticals Pte Ltd.
      Merck & Co, Inc.
      Melinta Therapeutics, Inc.
      Macrolide Pharmaceuticals, Inc.
      GlaxoSmithKline plc
      Furiex Pharmaceuticals, Inc.
      Durata Therapeutics, Inc.
      Debiopharm International S.A.
      Cempra, Inc.
      Bayer AG
      AstraZeneca
      Allergan plc.
      Albany Molecular Research, Inc.
      Actelion Pharmaceuticals Ltd.
      Abbott Laboratories, Inc.
      Buy now